These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 18984323)

  • 1. Rapporteur's Report Session 1: origin of the problem.
    Ross M
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S40-2. PubMed ID: 18984323
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapporteur's Report Session 2: characterization of fibrous minerals.
    Langer AM
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S73-4. PubMed ID: 18585423
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapporteur's Report Session 6: risk assessment of asbestos and other fibrous mineral particulates.
    Nolan RP; Langer AM
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S246-8. PubMed ID: 18585424
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk assessment due to environmental exposures to fibrous particulates associated with taconite ore.
    Wilson R; McConnell EE; Ross M; Axten CW; Nolan RP
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S232-45. PubMed ID: 18207296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origins of public concern with taconite and human health: Reserve Mining and the asbestos case.
    Berndt ME; Brice WC
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S31-9. PubMed ID: 18055081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International symposium on the health hazard evaluation of fibrous particles associated with taconite and the adjacent duluth complex. Introduction.
    Nolan RP
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S4. PubMed ID: 18984322
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of airborne and waterborne particles around a taconite ore processing facility.
    Axten CW; Foster D
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S66-72. PubMed ID: 18221826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapporteur's Report Session 3: exposure to grunerite (amosite) asbestos: historical perspectives of the health effects.
    Gibbs GW
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S91. PubMed ID: 18394767
    [No Abstract]   [Full Text] [Related]  

  • 9. Rapporteur's Report Session 4: grunerite asbestos (amosite) and tremolite-ferroactinolite asbestos: risk of environmental mesothelioma.
    Gamble JF
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S121-3. PubMed ID: 18501487
    [No Abstract]   [Full Text] [Related]  

  • 10. The search for asbestos within the Peter Mitchell Taconite iron ore mine, near Babbitt, Minnesota.
    Ross M; Nolan RP; Nord GL
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S43-50. PubMed ID: 18060674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapporteur's Report Session 5: assessment of health risk associated with exposure to non-asbestiform amphiboles including ingestion studies.
    Price B
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S204-6. PubMed ID: 18194828
    [No Abstract]   [Full Text] [Related]  

  • 12. Mineralogical and microscopic evaluation of coarse taconite tailings from Minnesota taconite operations.
    Zanko LM; Niles HB; Oreskovich JA
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S51-65. PubMed ID: 18166256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Data mining.
    Broderick R
    Minn Med; 2007 Sep; 90(9):26-30, 43. PubMed ID: 17966260
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mineral fibers and bladder cancer. Morphological and minerological investigations in a subject without professional exposure].
    Bellis D; Belluso E; Capella S; Coverlizza S; Ferraris G
    Pathologica; 2003 Jun; 95(3):157-61. PubMed ID: 12968311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to airborne amphibole structures and health risks: Libby, Montana.
    Price B
    Regul Toxicol Pharmacol; 2008 Oct; 52(1 Suppl):S97-S109. PubMed ID: 18006127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Environmental and occupational exposure to vitreous fibers: the initiatives of the European Commission].
    Aresini GA
    Med Lav; 1999; 90(1):84-7. PubMed ID: 10339956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unite to assess contaminant risk.
    Novak PJ
    Nature; 2011 Mar; 471(7340):578. PubMed ID: 21455163
    [No Abstract]   [Full Text] [Related]  

  • 18. Rapporteur's report on Session 4--exposure and dosimetry.
    Lin JC
    Prog Biophys Mol Biol; 2011 Dec; 107(3):464-6. PubMed ID: 21963413
    [No Abstract]   [Full Text] [Related]  

  • 19. [Apostles of being dirty are becoming popular].
    Hannuksela M
    Duodecim; 2004; 120(17):2043-4. PubMed ID: 15559012
    [No Abstract]   [Full Text] [Related]  

  • 20. [Possibilities and limits of human biomonitoring].
    Angerer J
    Schriftenr Ver Wasser Boden Lufthyg; 2000; 106():42-8. PubMed ID: 10981303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.